To determine whether increased ISG15 expression in ovarian cancer cells led to increased CD8+ lymphocyte density in tumor tissue, immunolocalization of CD8+ cells was performed on tumor nodules isolated from C57BL/6 immune-competent mice injected with ID8 or IG10 transfected with ISG15 or the mock control. The gene discussed is ISG15; the disease is neoplasm.